Insider · CIK 0002092279
John Bradley Holcomb
Files at INKT (MiNK Therapeutics, Inc.). First filing -, latest -.
In brief
John Bradley Holcomb files SEC Form 4 as director at INKT (MiNK Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; John Bradley Holcomb has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,233 | $10.95 | $14k | 4,691 | 42 d ago |
| Mar 2, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,239 | $10.90 | $14k | 2,367 | Jun 2, 2026 |
| Jun 1, 2026 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,091 | $12.38 | $14k | 3,458 | Jun 2, 2026 |
| Sep 23, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +4,174 | $0.00 | $0 | 4,174 | Apr 30, 2026 |
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | AGrant or award Common Stock | +1,128 | $11.09 | $13k | 1,128 | Dec 3, 2025 |
Questions about John Bradley Holcomb
Answered from the filings on this page, as of the latest one.
Is John Bradley Holcomb buying or selling?
John Bradley Holcomb has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did John Bradley Holcomb's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Bradley Holcomb has 0.
Where does John Bradley Holcomb file Form 4?
John Bradley Holcomb has filed Form 4 at INKT (MiNK Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.